GBT

Global Blood Therapeutics, Inc.

Healthcare

Set alert

Price alert · GBT

All alert types
68.49 0.00 0.00%
As of Oct 4, 2022
68.47 Day range 68.49

52-week range unavailable

Open
68.48
Prev close
68.49
Mkt cap
4.62B
Vol
3.28M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
68.47
High
68.49
Forward P/E
-29.14
Beta
0.46
Short ratio
2.11
Inst. own
111.41%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2022
50-d avg
63.70
200-d avg
38.56
1y target
64.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for GBT has not been loaded yet. Try again in a moment.

Valuation

P/E -6.1×
FY 2013: -51.9×FY 2014: -28.5×FY 2015: -8.9×FY 2016: -5.8×FY 2017: -14.3×FY 2018: -12.0×FY 2019: -17.4×FY 2020: -10.7×FY 2021: -6.1×
FY 2013 5y median -12.0× FY 2021
P/S 9.5×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 2199×FY 2020: 21.5×FY 2021: 9.5×
FY 2013 5y median 9.5× FY 2021
P/B 9.4×
FY 2013: -36.2×FY 2014: -12.0×FY 2015: 2.9×FY 2016: 2.6×FY 2017: 5.2×FY 2018: 3.7×FY 2019: 8.0×FY 2020: 6.4×FY 2021: 9.4×
FY 2013 5y median 6.4× FY 2021
P/FCF -7.1×
FY 2013: -60.1×FY 2014: -29.0×FY 2015: -13.0×FY 2016: -6.9×FY 2017: -17.3×FY 2018: -15.0×FY 2019: -23.4×FY 2020: -12.0×FY 2021: -7.1×
FY 2013 5y median -15.0× FY 2021
EV/EBITDA -6.5×
FY 2013: -53.3×FY 2014: -26.9×FY 2015: -5.8×FY 2016: -4.8×FY 2017: -12.7×FY 2018: -10.8×FY 2019: -17.2×FY 2020: -10.2×FY 2021: -6.5×
FY 2013 5y median -10.8× FY 2021
EV/Sales 9.3×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 2092×FY 2020: 18.7×FY 2021: 9.3×
FY 2013 5y median 9.3× FY 2021
FCF Yield -14.1%
FY 2013: -1.7%FY 2014: -3.4%FY 2015: -7.7%FY 2016: -14.4%FY 2017: -5.8%FY 2018: -6.7%FY 2019: -4.3%FY 2020: -8.3%FY 2021: -14.1%
FY 2013 5y median -6.7% FY 2021

Profitability

Gross Margin 98.3%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 97.7%FY 2020: 98.4%FY 2021: 98.3%
FY 2013 5y median 97.7% FY 2021
Operating Margin -147.4%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -13343.6%FY 2020: -196.4%FY 2021: -147.4%
FY 2013 5y median -147.4% FY 2021
Net Margin -155.6%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -12654.9%FY 2020: -200.0%FY 2021: -155.6%
FY 2013 5y median -155.6% FY 2021
ROE -154.3%
FY 2013: 69.7%FY 2014: 42.2%FY 2015: -32.9%FY 2016: -44.3%FY 2017: -36.7%FY 2018: -30.4%FY 2019: -46.1%FY 2020: -59.5%FY 2021: -154.3%
FY 2013 5y median -46.1% FY 2021
ROIC -33.5%
FY 2013: -649.6%FY 2014: -38.5%FY 2015: -32.6%FY 2016: -44.5%FY 2017: -36.1%FY 2018: -31.3%FY 2019: -38.7%FY 2020: -37.4%FY 2021: -33.5%
FY 2013 5y median -36.1% FY 2021
ROA -32.3%
FY 2013: -293.5%FY 2014: -37.3%FY 2015: -30.3%FY 2016: -40.7%FY 2017: -32.8%FY 2018: -28.2%FY 2019: -33.5%FY 2020: -34.2%FY 2021: -32.3%
FY 2013 5y median -32.8% FY 2021

Growth (YoY)

Revenue 57.3%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 5773.0%FY 2021: 57.3%
FY 2013 FY 2021
Operating Income -18.1%
FY 2013: 0.0%FY 2014: -31.0%FY 2015: -126.2%FY 2016: -79.2%FY 2017: -43.4%FY 2018: -53.2%FY 2019: -53.9%FY 2020: 13.5%FY 2021: -18.1%
FY 2013 FY 2021
EPS (diluted) -19.3%
FY 2013: 0.0%FY 2014: -81.9%FY 2015: -139.7%FY 2016: 31.5%FY 2017: -11.3%FY 2018: -23.6%FY 2019: -34.0%FY 2020: 11.6%FY 2021: -19.3%
FY 2013 FY 2021
Free Cash Flow -17.9%
FY 2013: 0.0%FY 2014: -30.7%FY 2015: -56.0%FY 2016: -116.7%FY 2017: -39.2%FY 2018: -45.9%FY 2019: -41.1%FY 2020: -11.5%FY 2021: -17.9%
FY 2013 FY 2021

Financial Health

Current Ratio 9.1×
FY 2013: 1.0×FY 2014: 21.1×FY 2015: 14.1×FY 2016: 9.7×FY 2017: 12.3×FY 2018: 14.4×FY 2019: 8.8×FY 2020: 8.0×FY 2021: 9.1×
FY 2013 5y median 9.1× FY 2021
Quick Ratio 8.5×
FY 2013: 1.0×FY 2014: 21.1×FY 2015: 14.1×FY 2016: 9.7×FY 2017: 12.3×FY 2018: 14.4×FY 2019: 8.8×FY 2020: 7.5×FY 2021: 8.5×
FY 2013 5y median 8.8× FY 2021
Debt / Equity 3.4×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.4×FY 2021: 3.4×
FY 2013 5y median 0.1× FY 2021
Net Debt / EBITDA 0.1×
FY 2013: 0.2×FY 2014: 2.6×FY 2015: 3.3×FY 2016: 1.1×FY 2017: 1.7×FY 2018: 1.6×FY 2019: 0.9×FY 2020: 1.5×FY 2021: 0.1×
FY 2013 5y median 1.5× FY 2021
Interest Coverage -18.6×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -24.8×FY 2021: -18.6×
FY 2013 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2013 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2013 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31